Titre : Profilage d'ADN

Profilage d'ADN : Questions médicales fréquentes

Termes MeSH sélectionnés :

Platelet Function Tests
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Profilage d'ADN : Questions médicales les plus fréquentes", "headline": "Profilage d'ADN : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Profilage d'ADN : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-01", "dateModified": "2025-03-28", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Profilage d'ADN" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Identification biométrique", "url": "https://questionsmedicales.fr/mesh/D056667", "about": { "@type": "MedicalCondition", "name": "Identification biométrique", "code": { "@type": "MedicalCode", "code": "D056667", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N04.452.910.099" } } }, "about": { "@type": "MedicalCondition", "name": "Profilage d'ADN", "alternateName": "DNA Fingerprinting", "code": { "@type": "MedicalCode", "code": "D016172", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Saqer S Alotaibi", "url": "https://questionsmedicales.fr/author/Saqer%20S%20Alotaibi", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Giuseppe Mannino", "url": "https://questionsmedicales.fr/author/Giuseppe%20Mannino", "affiliation": { "@type": "Organization", "name": "Plant Physiology Unit, Department of Life Sciences and Systems Biology, University of Turin, Via Quarello 15/a, 10135 Turin, Italy. giuseppe.mannino@unito.it." } }, { "@type": "Person", "name": "Massimo E Maffei", "url": "https://questionsmedicales.fr/author/Massimo%20E%20Maffei", "affiliation": { "@type": "Organization", "name": "Plant Physiology Unit, Department of Life Sciences and Systems Biology, University of Turin, Via Quarello 15/a, 10135 Turin, Italy. massimo.maffei@unito.it." } }, { "@type": "Person", "name": "Na Tian", "url": "https://questionsmedicales.fr/author/Na%20Tian", "affiliation": { "@type": "Organization", "name": "College of Traditional Chinese Medicine, Guangdong Pharmaceutical University Guangzhou 510006, China State Key Laboratory of Dao-di Herbs Breeding Base, National Resource Center for Chinese Materia Medica,China Academy of Chinese Medical Sciences Beijing 100700, China." } }, { "@type": "Person", "name": "Tian Zhang", "url": "https://questionsmedicales.fr/author/Tian%20Zhang", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Dao-di Herbs Breeding Base, National Resource Center for Chinese Materia Medica,China Academy of Chinese Medical Sciences Beijing 100700, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Testing P2Y12 platelet inhibitors generics beyond bioequivalence: a parallel single-blinded randomized trial.", "datePublished": "2022-08-17", "url": "https://questionsmedicales.fr/article/35978315", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12959-022-00405-y" } }, { "@type": "ScholarlyArticle", "name": "Anti-platelet agents inhibit platelet adhesion and aggregation on glass surface under physiological flow conditions: Toward a microfluidic platelet functional assay without additional adhesion protein modification.", "datePublished": "2023-11-23", "url": "https://questionsmedicales.fr/article/38032897", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/FJC.0000000000001514" } }, { "@type": "ScholarlyArticle", "name": "Platelet Glycoprotein Receptor Ia-C807T and IIIa-PlA1/PlA2 Genetic Polymorphisms Are Associated With Enhanced Platelet Function in Women With Recurrent Miscarriages.", "datePublished": "2023-10-27", "url": "https://questionsmedicales.fr/article/37899902", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7759/cureus.47832" } }, { "@type": "ScholarlyArticle", "name": "Association of Quality of Life and Visual Function in Glaucoma with Tests of Structure and Function.", "datePublished": "2024-09-12", "url": "https://questionsmedicales.fr/article/39259003", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/IJG.0000000000002495" } }, { "@type": "ScholarlyArticle", "name": "Integrated microfluidic multiple electrode aggregometry for point-of-care platelet function analysis.", "datePublished": "2024-09-18", "url": "https://questionsmedicales.fr/article/39291871", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1039/d4lc00469h" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Administration des services de santé", "item": "https://questionsmedicales.fr/mesh/D006298" }, { "@type": "ListItem", "position": 3, "name": "Organisation et administration", "item": "https://questionsmedicales.fr/mesh/D009934" }, { "@type": "ListItem", "position": 4, "name": "Mesures de sécurité", "item": "https://questionsmedicales.fr/mesh/D012637" }, { "@type": "ListItem", "position": 5, "name": "Identification biométrique", "item": "https://questionsmedicales.fr/mesh/D056667" }, { "@type": "ListItem", "position": 6, "name": "Profilage d'ADN", "item": "https://questionsmedicales.fr/mesh/D016172" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Profilage d'ADN - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Profilage d'ADN", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Profilage d'ADN", "description": "Comment le profilage d'ADN est-il utilisé dans le diagnostic ?\nQuels échantillons sont nécessaires pour le profilage d'ADN ?\nLe profilage d'ADN peut-il aider à identifier des maladies héréditaires ?\nLe profilage d'ADN est-il fiable ?\nPeut-on utiliser le profilage d'ADN pour des tests de parenté ?", "url": "https://questionsmedicales.fr/mesh/D016172?mesh_terms=Platelet+Function+Tests&page=18#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Profilage d'ADN", "description": "Quels symptômes peuvent indiquer un besoin de profilage d'ADN ?\nLe profilage d'ADN peut-il révéler des anomalies génétiques ?\nY a-t-il des symptômes psychologiques liés à l'utilisation de l'ADN ?\nLe profilage d'ADN peut-il aider à diagnostiquer des maladies ?\nQuels impacts émotionnels le profilage d'ADN peut-il avoir ?", "url": "https://questionsmedicales.fr/mesh/D016172?mesh_terms=Platelet+Function+Tests&page=18#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Profilage d'ADN", "description": "Le profilage d'ADN peut-il aider à la prévention des maladies ?\nComment le profilage d'ADN est-il utilisé en santé publique ?\nLe profilage d'ADN peut-il influencer le mode de vie ?\nY a-t-il des programmes de prévention basés sur le profilage d'ADN ?\nLe profilage d'ADN est-il accessible pour la prévention ?", "url": "https://questionsmedicales.fr/mesh/D016172?mesh_terms=Platelet+Function+Tests&page=18#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Profilage d'ADN", "description": "Le profilage d'ADN est-il utilisé pour des traitements médicaux ?\nComment le profilage d'ADN influence-t-il les traitements ?\nLe profilage d'ADN peut-il prédire l'efficacité d'un traitement ?\nY a-t-il des traitements spécifiques basés sur le profilage d'ADN ?\nLe profilage d'ADN est-il utilisé dans la recherche de nouveaux traitements ?", "url": "https://questionsmedicales.fr/mesh/D016172?mesh_terms=Platelet+Function+Tests&page=18#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Profilage d'ADN", "description": "Quelles complications peuvent survenir avec le profilage d'ADN ?\nLe profilage d'ADN peut-il entraîner des erreurs d'identification ?\nY a-t-il des risques de confidentialité avec le profilage d'ADN ?\nLe profilage d'ADN peut-il causer des conflits familiaux ?\nQuelles sont les implications légales du profilage d'ADN ?", "url": "https://questionsmedicales.fr/mesh/D016172?mesh_terms=Platelet+Function+Tests&page=18#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Profilage d'ADN", "description": "Quels facteurs influencent la nécessité de profilage d'ADN ?\nLe profilage d'ADN est-il plus fréquent dans certaines populations ?\nLes antécédents médicaux influencent-ils le profilage d'ADN ?\nY a-t-il des facteurs environnementaux liés au profilage d'ADN ?\nLe mode de vie affecte-t-il le besoin de profilage d'ADN ?", "url": "https://questionsmedicales.fr/mesh/D016172?mesh_terms=Platelet+Function+Tests&page=18#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment le profilage d'ADN est-il utilisé dans le diagnostic ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Il permet d'identifier des individus dans des enquêtes criminelles ou des tests de paternité." } }, { "@type": "Question", "name": "Quels échantillons sont nécessaires pour le profilage d'ADN ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des échantillons de sang, de salive ou de cheveux peuvent être utilisés." } }, { "@type": "Question", "name": "Le profilage d'ADN peut-il aider à identifier des maladies héréditaires ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut révéler des prédispositions génétiques à certaines maladies." } }, { "@type": "Question", "name": "Le profilage d'ADN est-il fiable ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est considéré comme très fiable avec un faible taux d'erreur." } }, { "@type": "Question", "name": "Peut-on utiliser le profilage d'ADN pour des tests de parenté ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est couramment utilisé pour établir des liens de parenté." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un besoin de profilage d'ADN ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Il n'y a pas de symptômes physiques, mais des situations légales ou familiales peuvent l'exiger." } }, { "@type": "Question", "name": "Le profilage d'ADN peut-il révéler des anomalies génétiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Indirectement, il peut indiquer des risques génétiques, mais ce n'est pas son but principal." } }, { "@type": "Question", "name": "Y a-t-il des symptômes psychologiques liés à l'utilisation de l'ADN ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des résultats inattendus peuvent causer du stress ou de l'anxiété chez les individus." } }, { "@type": "Question", "name": "Le profilage d'ADN peut-il aider à diagnostiquer des maladies ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Il peut aider à identifier des prédispositions, mais ne diagnostique pas directement des maladies." } }, { "@type": "Question", "name": "Quels impacts émotionnels le profilage d'ADN peut-il avoir ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Il peut provoquer des révélations sur l'identité ou des liens familiaux, entraînant des émotions fortes." } }, { "@type": "Question", "name": "Le profilage d'ADN peut-il aider à la prévention des maladies ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut identifier des risques génétiques, permettant des mesures préventives." } }, { "@type": "Question", "name": "Comment le profilage d'ADN est-il utilisé en santé publique ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Il aide à surveiller les maladies génétiques et à planifier des interventions de santé." } }, { "@type": "Question", "name": "Le profilage d'ADN peut-il influencer le mode de vie ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les résultats peuvent inciter à adopter des comportements plus sains." } }, { "@type": "Question", "name": "Y a-t-il des programmes de prévention basés sur le profilage d'ADN ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Certaines initiatives de santé utilisent le profilage pour cibler des populations à risque." } }, { "@type": "Question", "name": "Le profilage d'ADN est-il accessible pour la prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "L'accès varie selon les pays et les systèmes de santé, mais il devient plus courant." } }, { "@type": "Question", "name": "Le profilage d'ADN est-il utilisé pour des traitements médicaux ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Non, il n'est pas un traitement, mais peut guider des décisions thérapeutiques." } }, { "@type": "Question", "name": "Comment le profilage d'ADN influence-t-il les traitements ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il peut aider à choisir des traitements adaptés en fonction des prédispositions génétiques." } }, { "@type": "Question", "name": "Le profilage d'ADN peut-il prédire l'efficacité d'un traitement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut indiquer comment un patient réagira à certains médicaments." } }, { "@type": "Question", "name": "Y a-t-il des traitements spécifiques basés sur le profilage d'ADN ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certains traitements ciblés en oncologie utilisent des informations génétiques." } }, { "@type": "Question", "name": "Le profilage d'ADN est-il utilisé dans la recherche de nouveaux traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est essentiel pour identifier des cibles thérapeutiques dans la recherche." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec le profilage d'ADN ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications éthiques et psychologiques peuvent survenir, comme la stigmatisation." } }, { "@type": "Question", "name": "Le profilage d'ADN peut-il entraîner des erreurs d'identification ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Bien que rare, des erreurs peuvent se produire, entraînant des conséquences juridiques." } }, { "@type": "Question", "name": "Y a-t-il des risques de confidentialité avec le profilage d'ADN ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la confidentialité des données génétiques est une préoccupation majeure." } }, { "@type": "Question", "name": "Le profilage d'ADN peut-il causer des conflits familiaux ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des résultats inattendus peuvent révéler des secrets familiaux, entraînant des tensions." } }, { "@type": "Question", "name": "Quelles sont les implications légales du profilage d'ADN ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Il peut soulever des questions juridiques concernant la propriété des données et l'utilisation." } }, { "@type": "Question", "name": "Quels facteurs influencent la nécessité de profilage d'ADN ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme l'hérédité, l'histoire familiale et des enquêtes criminelles peuvent influencer." } }, { "@type": "Question", "name": "Le profilage d'ADN est-il plus fréquent dans certaines populations ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines populations peuvent être plus souvent testées en raison de prédispositions génétiques." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils le profilage d'ADN ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies peuvent justifier un profilage d'ADN." } }, { "@type": "Question", "name": "Y a-t-il des facteurs environnementaux liés au profilage d'ADN ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs environnementaux peuvent interagir avec des prédispositions génétiques, influençant la santé." } }, { "@type": "Question", "name": "Le mode de vie affecte-t-il le besoin de profilage d'ADN ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie à risque peut inciter à un profilage pour évaluer des risques génétiques." } } ] } ] }

Sources (10000 au total)

Platelet Glycoprotein Receptor Ia-C807T and IIIa-PlA1/PlA2 Genetic Polymorphisms Are Associated With Enhanced Platelet Function in Women With Recurrent Miscarriages.

Thrombophilic genetic polymorphisms of the platelet glycoproteins Ia (GpIa) and IIIa (GpIIIa) have been associated with an increased risk of recurrent miscarriages. The aim of this study was to invest... This cross-sectional study comprised 196 unrelated nulliparous Greek women with a history of unexplained recurrent miscarriages. Patients were genotyped for the presence of the GpIa-C807T (rs1126643) ... In the total population of women with recurrent miscarriages, the COL/EPI CT ranged from 70 to 160 seconds (median: 122 seconds, interquartile range (IQR): 102.3-138 seconds). In comparison with the d... The GpIa-C807T and GpIIIa-PlA1/PlA2 polymorphisms and more pronouncedly the combined carriers of the risk variants are associated with enhanced platelet reactivity expressed via shorter COL/EPI CT. Th...

Association of Quality of Life and Visual Function in Glaucoma with Tests of Structure and Function.

In addition to standard automated perimetry tests, contrast sensitivity testing and macular analyses may predict changes in the quality of life in patients at different stages of glaucoma.... To examine the relationship between functional and structural tests of visual function and the 25-item National Eye Institute-Visual Function Questionnaire (NEI-VFQ-25) and the 36-item Short Form Heal... Standard automated perimetry tests, optical coherence tomography scans, and contrast sensitivity (CS) testing were prospectively performed in 160 patients with glaucoma. The Hoddap-Parrish-Anderson st... The study group comprised 29 patients with suspected glaucoma, 104 with mild glaucoma, 15 with moderate glaucoma, and 12 with severe glaucoma. The mean total score of the NEI-VFQ-25 was 88.8±8.2. The ... VA correlated the most with quality of life in glaucoma patients, as measured with the NEI-VFQ-25 to assess quality of life in glaucoma. The impact of visual functions on quality of life varies at dif...

Alterations in visible light exposure modulate platelet function and regulate thrombus formation.

Variations in light exposure are associated with changes in inflammation and coagulation. The impact of light spectra on venous (VT) and arterial thrombosis is largely unexplored.... To investigate the impact of altering light spectrum on platelet function in thrombosis.... Wild type (WT) C57BL/6J mice were exposed to ambient (mice... Exposure to long wavelength red light resulted in reduced platelet aggregation and activation. RNA-seq analysis demonstrated no significant transcriptomic changes between mice... Light therapy may be a promising approach to thrombus prophylaxis by specifically targeting the intersection between innate immune function and coagulation....

Thrombocytopenia in SFTS due to platelets with altered function undergoing cell death pathways.

Thrombocytopenia is the major clinical feature associated with the severity of SFTS, but the mechanism by which it occurs remains unclear.... RNA transcriptome analyses were performed on platelets purified from SFTS patients and SFTSV-infected mice. The functions of differentially expressed genes (DEGs) in the platelets were characterized. ... Enhanced neutrophil activation and interferon (IFN) signaling involved in the viral life cycle were common platelet responses in SFTS, which may consume increasing numbers of platelets. Other function... The altered functions of platelets, such as mediating leukocyte activation and undergoing cell death, contribute to thrombocytopenia in SFTS patients. The different mechanisms of thrombocytopenia in m...

The bleeding diathesis in patients with hereditary haemorrhagic telangiectasia is not due to impaired platelet function.

Patients with the rare disease; Hereditary haemorrhagic telangiectasia (HHT) often bleed from telangiectatic lesions in mucosal surfaces. Studies suggest that impaired platelet function may also play ... We conducted a case-control study based on a sample size calculation and included 22 HHT-patients (inclusion criteria: epistaxis severity score ≥ 4, no intake of medicine affecting platelet function t... We found no significant difference in mean platelet volume and immature platelet fraction and no difference in platelet activation as measured by exposure of CD62P, CD63P and PAC1 binding. Nor did we ... Reduced platelet function is unlikely to contribute to the frequent and long bleeding episodes that HHT-patients suffer from. We propose that further studies should focus on whether patients with HHT ...

The modulation of platelet function by growth hormone in growth hormone deficient Hypopituitary patients.

Growth hormone deficiency (GHD) has been implicated in increased cardiovascular and cerebrovascular disease risk seen in hypopituitarism, however the mechanism remains speculative. We hypothesise that... This study utilizes a physiological flow-based assay to quantify platelet function in whole blood from patient cohorts under arterial shear. Thirteen GH Naïve hypopituitary adults with GHD and thirtee... We found a significantly altered profile of platelet-vWF interactions in GHD individuals compared to healthy controls. Specifically, we observed a marked increase in platelets shown to form associatio... Taken together observed differences in platelet behaviour may contribute to an increased risk of thrombosis in GHD which can in part be reversed by GH therapy....

Platelets retain function and can be stored following disruption of human leucocyte antigens.

Antibodies to human leucocyte antigen (HLA) Class-I antigens can lead to refractoriness to platelet transfusion. Although this can be overcome by transfusion of HLA-compatible platelets, they are not ... Platelet components were treated with 0.9% saline or citric acid solution (pH 3.0), and then stored until expiry (Day 7). HLA and platelet glycoprotein expression, platelet viability, activation and s... Acid treatment reduced detection of HLA Class-I on platelets by 75%, with significant reductions in reactivity to patient anti-sera. Acid treatment reduced platelet content and viability, increased pl... Although HLA disruption had some detrimental effects, acid-treated platelets remained functional, retaining their capacity to respond to agonists and form clots, and with further development could be ...